P11388 TOP2A_HUMAN
Gene name: TOP2A
Protein name: DNA topoisomerase 2-alpha
List of molecules and drugs that target protein P11388
# | DrugDomain Data | DrugBank Accession | Name | Drug action | Affinity data | InChI Key | SMILES |
---|---|---|---|---|---|---|---|
1 | P11388_DB00218 | DB00218 | Moxifloxacin | inhibitor | FABPRXSRWADJSP-MEDUHNTESA-N | [H][C@]12CN(C[C@@]1([H])NCCC2)C1=C(F)C=C2C(=O)C(=CN(C3CC3)C2=C1OC)C(O)=O | |
2 | P11388_DB00276 | DB00276 | Amsacrine | inhibitor | IC50(nM) = 1000.0 EC50(nM) = 720.0 | XCPGHVQEEXUHNC-UHFFFAOYSA-N | COC1=C(NC2=C3C=CC=CC3=NC3=CC=CC=C23)C=CC(NS(C)(=O)=O)=C1 |
3 | P11388_DB00380 | DB00380 | Dexrazoxane | inhibitor | BMKDZUISNHGIBY-ZETCQYMHSA-N | C[C@@H](CN1CC(=O)NC(=O)C1)N1CC(=O)NC(=O)C1 | |
4 | P11388_DB00385 | DB00385 | Valrubicin | inhibitor | ZOCKGBMQLCSHFP-KQRAQHLDSA-N | [H][C@@]1(C[C@@](O)(CC2=C(O)C3=C(C(O)=C12)C(=O)C1=C(OC)C=CC=C1C3=O)C(=O)COC(=O)CCCC)O[C@H]1C[C@H](NC(=O)C(F)(F)F)[C@H](O)[C@H](C)O1 | |
5 | P11388_DB00444 | DB00444 | Teniposide | inhibitor | NRUKOCRGYNPUPR-QBPJDGROSA-N | [H][C@]12COC(=O)[C@]1([H])[C@H](C1=CC(OC)=C(O)C(OC)=C1)C1=C(C=C3OCOC3=C1)[C@H]2O[C@]1([H])O[C@]2([H])CO[C@H](O[C@@]2([H])[C@H](O)[C@H]1O)C1=CC=CS1 | |
6 | P11388_DB00445 | DB00445 | Epirubicin | inhibitor | AOJJSUZBOXZQNB-VTZDEGQISA-N | COC1=CC=CC2=C1C(=O)C1=C(O)C3=C(C[C@](O)(C[C@@H]3O[C@H]3C[C@H](N)[C@@H](O)[C@H](C)O3)C(=O)CO)C(O)=C1C2=O | |
7 | P11388_DB00467 | DB00467 | Enoxacin | inhibitor | IDYZIJYBMGIQMJ-UHFFFAOYSA-N | CCN1C=C(C(O)=O)C(=O)C2=CC(F)=C(N=C12)N1CCNCC1 | |
8 | P11388_DB00487 | DB00487 | Pefloxacin | inhibitor | FHFYDNQZQSQIAI-UHFFFAOYSA-N | CCN1C=C(C(O)=O)C(=O)C2=CC(F)=C(C=C12)N1CCN(C)CC1 | |
9 | P11388_DB00537 | DB00537 | Ciprofloxacin | inhibitor | IC50(nM) = 100000.0 EC50(nM) = 30.0 | MYSWGUAQZAJSOK-UHFFFAOYSA-N | OC(=O)C1=CN(C2CC2)C2=CC(N3CCNCC3)=C(F)C=C2C1=O |
10 | P11388_DB00685 | DB00685 | Trovafloxacin | inhibitor | WVPSKSLAZQPAKQ-CDMJZVDBSA-N | [H][C@@]12CN(C[C@]1([H])[C@H]2N)C1=NC2=C(C=C1F)C(=O)C(=CN2C1=C(F)C=C(F)C=C1)C(O)=O | |
11 | P11388_DB00694 | DB00694 | Daunorubicin | inhibitor | STQGQHZAVUOBTE-VGBVRHCVSA-N | COC1=CC=CC2=C1C(=O)C1=C(O)C3=C(C[C@](O)(C[C@@H]3O[C@H]3C[C@H](N)[C@H](O)[C@H](C)O3)C(C)=O)C(O)=C1C2=O | |
12 | P11388_DB00773 | DB00773 | Etoposide | inhibitor | IC50(nM) = 21800.0 EC50(nM) = 810.0 | VJJPUSNTGOMMGY-MRVIYFEKSA-N | [H][C@]12COC(=O)[C@]1([H])[C@H](C1=CC(OC)=C(O)C(OC)=C1)C1=CC3=C(OCO3)C=C1[C@H]2O[C@@H]1O[C@]2([H])CO[C@@H](C)O[C@@]2([H])[C@H](O)[C@H]1O |
13 | P11388_DB00978 | DB00978 | Lomefloxacin | inhibitor | ZEKZLJVOYLTDKK-UHFFFAOYSA-N | CCN1C=C(C(O)=O)C(=O)C2=CC(F)=C(N3CCNC(C)C3)C(F)=C12 | |
14 | P11388_DB00997 | DB00997 | Doxorubicin | inhibitor | IC50(nM) = 600.0 | AOJJSUZBOXZQNB-TZSSRYMLSA-N | COC1=CC=CC2=C1C(=O)C1=C(O)C3=C(C[C@](O)(C[C@@H]3O[C@H]3C[C@H](N)[C@H](O)[C@H](C)O3)C(=O)CO)C(O)=C1C2=O |
15 | P11388_DB01059 | DB01059 | Norfloxacin | inhibitor | OGJPXUAPXNRGGI-UHFFFAOYSA-N | CCN1C=C(C(O)=O)C(=O)C2=CC(F)=C(C=C12)N1CCNCC1 | |
16 | P11388_DB01165 | DB01165 | Ofloxacin | inhibitor | GSDSWSVVBLHKDQ-UHFFFAOYSA-N | CC1COC2=C3N1C=C(C(O)=O)C(=O)C3=CC(F)=C2N1CCN(C)CC1 | |
17 | P11388_DB01177 | DB01177 | Idarubicin | inhibitor | XDXDZDZNSLXDNA-TZNDIEGXSA-N | C[C@@H]1O[C@H](C[C@H](N)[C@@H]1O)O[C@H]1C[C@@](O)(CC2=C1C(O)=C1C(=O)C3=CC=CC=C3C(=O)C1=C2O)C(C)=O | |
18 | P11388_DB01179 | DB01179 | Podofilox | inhibitor | YJGVMLPVUAXIQN-XVVDYKMHSA-N | [H][C@]12COC(=O)[C@]1([H])[C@H](C1=CC(OC)=C(OC)C(OC)=C1)C1=CC3=C(OCO3)C=C1[C@@H]2O | |
19 | P11388_DB01204 | DB01204 | Mitoxantrone | inhibitor | IC50(nM) = 5300.0 | KKZJGLLVHKMTCM-UHFFFAOYSA-N | OCCNCCNC1=CC=C(NCCNCCO)C2=C1C(=O)C1=C(C(O)=CC=C1O)C2=O |
20 | P11388_DB01208 | DB01208 | Sparfloxacin | inhibitor | DZZWHBIBMUVIIW-DTORHVGOSA-N | C[C@H]1CN(C[C@@H](C)N1)C1=C(F)C(N)=C2C(=O)C(=CN(C3CC3)C2=C1F)C(O)=O | |
21 | P11388_DB01645 | DB01645 | Genistein | n/a | IC50(nM) = 111000.0 | TZBJGXHYKVUXJN-UHFFFAOYSA-N | OC1=CC=C(C=C1)C1=COC2=C(C(O)=CC(O)=C2)C1=O |
22 | P11388_DB04576 | DB04576 | Fleroxacin | inhibitor | XBJBPGROQZJDOJ-UHFFFAOYSA-N | CN1CCN(CC1)C1=C(F)C=C2C(=O)C(=CN(CCF)C2=C1F)C(O)=O | |
23 | P11388_DB04967 | DB04967 | Lucanthone | inhibitor | FBQPGGIHOFZRGH-UHFFFAOYSA-N | CCN(CC)CCNC1=C2C(=O)C3=CC=CC=C3SC2=C(C)C=C1 | |
24 | P11388_DB04975 | DB04975 | Banoxantrone | n/a | YZBAXVICWUUHGG-UHFFFAOYSA-N | C[N+](C)([O-])CCNC1=CC=C(NCC[N+](C)(C)[O-])C2=C1C(=O)C1=C(O)C=CC(O)=C1C2=O | |
25 | P11388_DB05022 | DB05022 | Amonafide | n/a | UPALIKSFLSVKIS-UHFFFAOYSA-N | CN(C)CCN1C(=O)C2=CC=CC3=CC(N)=CC(C1=O)=C23 | |
26 | P11388_DB05129 | DB05129 | Elsamitrucin | n/a | MGQRRMONVLMKJL-KWJIQSIXSA-N | CO[C@@H]1[C@@H](N)[C@@H](O[C@H]2[C@H](OC3=CC=CC4=C3C3=C5C(C(=O)OC6=C5C(=C(C)C=C6)C(=O)O3)=C4O)O[C@H](C)[C@H](O)[C@]2(C)O)O[C@H](C)[C@@H]1O | |
27 | P11388_DB05706 | DB05706 | 13-deoxydoxorubicin | n/a | RGVRUQHYQSORBY-JIGXQNLBSA-N | COC1=C2C(=O)C3=C(O)C4=C(C[C@@](O)(CCO)C[C@@H]4O[C@H]4C[C@H](N)[C@H](O)[C@H](C)O4)C(O)=C3C(=O)C2=CC=C1 | |
28 | P11388_DB06013 | DB06013 | Aldoxorubicin | inhibitor | OBMJQRLIQQTJLR-USGQOSEYSA-N | COC1=C2C(=O)C3=C(O)C4=C(C[C@](O)(C[C@@H]4O[C@H]4C[C@H](N)[C@H](O)[C@H](C)O4)C(\CO)=N\NC(=O)CCCCCN4C(=O)C=CC4=O)C(O)=C3C(=O)C2=CC=C1 | |
29 | P11388_DB06263 | DB06263 | Amrubicin | n/a | VJZITPJGSQKZMX-XDPRQOKASA-N | [H][C@@]1(C[C@@](N)(CC2=C1C(O)=C1C(=O)C3=CC=CC=C3C(=O)C1=C2O)C(C)=O)O[C@H]1C[C@H](O)[C@H](O)CO1 | |
30 | P11388_DB06362 | DB06362 | Becatecarin | n/a | JSKFWUPVIZYJMR-UDOAKELVSA-N | CCN(CC)CCN1C(=O)C2=C(C1=O)C1=C(N([C@@H]3O[C@H](CO)[C@@H](OC)[C@H](O)[C@H]3O)C3=C(Cl)C=CC=C13)C1=C2C2=C(N1)C(Cl)=CC=C2 | |
31 | P11388_DB06420 | DB06420 | Annamycin | n/a | CIDNKDMVSINJCG-GKXONYSUSA-N | C[C@@H]1O[C@@H](O[C@H]2C[C@@](O)(CC3=C2C(O)=C2C(=O)C4=CC=CC=C4C(=O)C2=C3O)C(=O)CO)[C@H](I)[C@H](O)[C@H]1O | |
32 | P11388_DB06421 | DB06421 | Declopramide | n/a | YEYAKZXEBSVURO-UHFFFAOYSA-N | CCN(CC)CCNC(=O)C1=CC=C(N)C(Cl)=C1 | |
33 | P11388_DB09047 | DB09047 | Finafloxacin | inhibitor | FYMHQCNFKNMJAV-HOTGVXAUSA-N | [H][C@]12CN(C[C@]1([H])OCCN2)C1=C(F)C=C2C(=O)C(=CN(C3CC3)C2=C1C#N)C(O)=O |